It'll Help on the Balance Sheet, Too

Dec 24, 2008

How's this for belt-tightening? The Wall Street Journal reports that GlaxoSmithKline has announced it will "no longer use corporate funds for political contributions as part of an effort to improve openness in its business," according to the article. The company donated more than $585,000 in the US this year. (The company adopted this same policy in Europe in 2001.) No word, though, on whether that money will be redirected to R&D.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

P.1 Re-infection Concerns

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

Aiming for May

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

NIH Program to Address Structural Racism

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

PNAS Papers on Myelopathy GWAS in Japan, Hypertrophic Cardiomyopathy, MRSA Methylation

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.

Menu